Banner

August 22, 2008

New (Free) U.S. Guide To Phase IV

Outcome: Why Good Registries Matter

A thought leader in the post-approval space, Outcome’s Richard Gliklich talks about a new reference work that he had a hand in. He believes well-designed registries could put regulatory agencies, academic experts and the general public at ease.

thumbnail
New (Free) U.S. Guide To Phase IV

Outcome: Why Good Registries Matter

June 15, 2007

By Mark Uehling

With Congress poised to legislate new mandates for post-approval studies, it seemed like a good time to talk to Richard Gliklich, the president of Outcome and a professor of surgery at Harvard Medical School. We covered his company’s substantive conference…

No articles available